Click to Share
 

Biologics Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By Cambridge Healthtech Institute
Over 1,300 biotherapeutics industry experts will convene at PepTalk: The Protein Science Week to share insight and perspective on the evolution of biologics, and the generation, characterization, and clinical application of proteins.
By Cambridge Healthtech Institute
Scientists from around the world will convene to share practical applications and case studies in protein & antibody engineering and novel biotherapeutics development.
By Cambridge Healthtech Institute
World-renowned thought leaders share insights & best practices, discover industry trends and find solutions to current challenges
By Cambridge Healthtech Institute
Over 1,200 biotherapeutics industry experts will convene at this annual event to share insight and perspective on the evolution of biologics, and the generation, characterization, and clinical application of proteins.
By NAPSRx
The FDA’s Fast Track program has been implemented to accelerate the development and review of drugs to treat serious conditions and fill an unmet medical need
12374293
By Cambridge Healthtech Institute
Discussions will include a variety of issues on how to expedite your biologic to the market safely by overcoming immunogenicity assessment challenges, adopting prediction and mitigation approaches, and selecting the right bioassay.
By marcus evans
Interview with Richard DiCicco, Chairman with Harvest Moon Pharmaceuticals, on key topics to be discussed at the upcoming marcus evans 7th Product & Pipeline Enhancement for Generics Conference, on July 30-31, 2014 in Alexandria, VA
By Carmell Therapeutics Corp.
Carmell Therapeutics, a company that is developing novel products manufactured from blood plasma, which naturally accelerate the healing of injured tissues, is pleased to announce that it has been awarded a Phase I Small Business Innovation Research...
12296850
By SMi Group Ltd
SMi Group Reports: representatives over 55 companies will meet in Iselin, NJ, to discuss the latest achievements in the pre-filled syringe marketplace, developments in drug stabilisation and material interactions.
By Cambridge Healthtech Institute
Driving Innovation Through New Targets, Effective Tools, Next-Gen and Alternate Delivery Technologies
By Cambridge Healthtech Institute
Overcoming Challenges in Injectable Drug Delivery via Breakthrough Delivery and Device Strategies
By BioCapacity On Demand, LLC
Co-Manufacturing Agreement between BioCapacity On Demand and Medical Coaches Reached
By Cambridge Healthtech Institute
Over 1,600 scientists will convene at this annual event to celebrate the evolution of biologics, and the generation, characterization, and clinical application of proteins.
12270548
By Cambridge Healthtech Institute
Ten fellowship award winners will receive a poster presentation slot and a discounted registration rate of $195.* Full-time graduate students and Ph.D. candidates should apply. The summit will take place on May 5-7, 2014 in Boston, MA.
12266100
By Cambridge Healthtech Institute
Shaping the Future of Delivering Biotherapeutics - What's on the Horizon
12252246
By smi group
SMi's Biosimilars: Commercial Strategies and Regulatory Guidelines masterclass, taking place on the 9 December in London, will address the common pitfalls in and around biosimilar regulatory requirements in both Europe and the US.
By Cambridge Healthtech Institute
New programs focused on “Antibody Optimization and Development” and “Manufacturing and Facilities” added to PepTalk 2014
By Cambridge Healthtech Institute
Dr. Lathey sits down with conference producer Samantha Lewis to discuss the biggest challenges to managing bioassay variability, tools and strategies that researchers are using to combat it, and how procedural variation can have unwanted effects.
By K2M Spine
The launch of this new addition to the VESUVIUS product family demonstrates K2M’s continued focus on growing our presence in the biologics market
By Cambridge Healthtech Institute
Chemical Computing Group will host a dinner short course in Boston, MA, on June 19, 2013, from 6:00-8:00 pm, on the conclusion of day one of CHI/Bio-IT World’s 13th annual Structure-Based Drug Design (SBDD) conference taking place at the Revere Hotel...

All Press Releases

By Cambridge Healthtech Institute
Moderated by Drs. Han Li, Bristol-Myers Squibb; Maura C. Kibbey, United States Pharmacopeia (USP); and Max L. Tejada, Gilead Sciences
By Cambridge Healthtech Institute
Over 1,300 biotherapeutics industry experts will convene at PepTalk: The Protein Science Week to share insight and perspective on the evolution of biologics, and the generation, characterization, and clinical application of proteins.
By SMi Group
SMi's Biosimilars and Biobetters conference, taking place on 30 September - 1 October 2015 in London, will address pharmacovigilance of biosimilars, patent litigation, market access, product commercialisation barriers and global market developments.
By Visiongain
LONDON, UK. 15th of June 2015: A new report by visiongain predicts that the world market for drug delivery technologies will reach $159.3bn in 2015.
By SMi Group
SMi's Biosimilars and Biobetters conference, taking place on 30 September - 1 October 2015 in London, will address pharmacovigilance of biosimilars, patent litigation, market access, product commercialisation barriers and global market developments.
By SMi Group
SMi's 6th annual Biosimilars and Biobetters conference, taking place on 30th September - 1st October 2015 in London, will cover regulatory updates, pharmacovigilance of biosimilars, patent litigation, market access and global market developments.
By Cambridge Healthtech Institute
Scientists from around the world will convene to share practical applications and case studies in protein & antibody engineering and novel biotherapeutics development.
By Cambridge Healthtech Institute
World-renowned thought leaders share insights & best practices, discover industry trends and find solutions to current challenges
By Cambridge Healthtech Institute
Over 1,200 biotherapeutics industry experts will convene at this annual event to share insight and perspective on the evolution of biologics, and the generation, characterization, and clinical application of proteins.
By NAPSRx
The FDA’s Fast Track program has been implemented to accelerate the development and review of drugs to treat serious conditions and fill an unmet medical need
12374293
By Cambridge Healthtech Institute
Discussions will include a variety of issues on how to expedite your biologic to the market safely by overcoming immunogenicity assessment challenges, adopting prediction and mitigation approaches, and selecting the right bioassay.
By marcus evans
Interview with Richard DiCicco, Chairman with Harvest Moon Pharmaceuticals, on key topics to be discussed at the upcoming marcus evans 7th Product & Pipeline Enhancement for Generics Conference, on July 30-31, 2014 in Alexandria, VA
By Carmell Therapeutics Corp.
Carmell Therapeutics, a company that is developing novel products manufactured from blood plasma, which naturally accelerate the healing of injured tissues, is pleased to announce that it has been awarded a Phase I Small Business Innovation Research...
12296850
By SMi Group Ltd
SMi Group Reports: representatives over 55 companies will meet in Iselin, NJ, to discuss the latest achievements in the pre-filled syringe marketplace, developments in drug stabilisation and material interactions.
By Cambridge Healthtech Institute
Driving Innovation Through New Targets, Effective Tools, Next-Gen and Alternate Delivery Technologies
By Cambridge Healthtech Institute
Overcoming Challenges in Injectable Drug Delivery via Breakthrough Delivery and Device Strategies
By BioCapacity On Demand, LLC
Co-Manufacturing Agreement between BioCapacity On Demand and Medical Coaches Reached
By Cambridge Healthtech Institute
Over 1,600 scientists will convene at this annual event to celebrate the evolution of biologics, and the generation, characterization, and clinical application of proteins.
12270548
By Cambridge Healthtech Institute
Ten fellowship award winners will receive a poster presentation slot and a discounted registration rate of $195.* Full-time graduate students and Ph.D. candidates should apply. The summit will take place on May 5-7, 2014 in Boston, MA.
12266100
By Cambridge Healthtech Institute
Shaping the Future of Delivering Biotherapeutics - What's on the Horizon
By BRDG Park
Combination of biologicals and big data creates opportunities for investors
12252246
By smi group
SMi's Biosimilars: Commercial Strategies and Regulatory Guidelines masterclass, taking place on the 9 December in London, will address the common pitfalls in and around biosimilar regulatory requirements in both Europe and the US.
By Cambridge Healthtech Institute
New programs focused on “Antibody Optimization and Development” and “Manufacturing and Facilities” added to PepTalk 2014
By Cambridge Healthtech Institute
Dr. Lathey sits down with conference producer Samantha Lewis to discuss the biggest challenges to managing bioassay variability, tools and strategies that researchers are using to combat it, and how procedural variation can have unwanted effects.
By K2M Spine
The launch of this new addition to the VESUVIUS product family demonstrates K2M’s continued focus on growing our presence in the biologics market
By Cambridge Healthtech Institute
Chemical Computing Group will host a dinner short course in Boston, MA, on June 19, 2013, from 6:00-8:00 pm, on the conclusion of day one of CHI/Bio-IT World’s 13th annual Structure-Based Drug Design (SBDD) conference taking place at the Revere Hotel...
By ThermoPod
Slim, trim thermal packaging liners save up to 70% on shippers' pallets + shelves compared to foam packaging and coolers, enabling better control of storage requirements. And unlike with foam packaging, the liners are disposable in ordinary trash.
11935684
By SMi Group
Variations in global regulatory strategy for biosimilars outside Europe, Japan and the US
By visiongain
A new report by visiongain, a London-based business information company, predicts that global revenues for biosimilars will reach $1.6 billion in 2012.
By Cambridge Healthtech Institute
Those that missed last month's event can get a CD with 350 speaker presentations from 16 conferences within 4 scientific channels: diagnostics, drug discovery & development, informatics and cancer. TriConference.com

Page:
Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share